Clinical trial · Interventional
Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
A Prospective, Randomized Trial of Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pancreaticoduodenectomy is associated with a high incidence of postoperative complications. These postoperative complications could delay postoperative resumption of adequate oral intake. Clinical study on postoperative feeding after pancreaticoduodenectomy is very limited. Method of Nutritional support (Enteral feeding or total parenteral support)after pancreaticoduodenectomy is controversial. 1. To evaluate whether early enteral nutrition may be a suitable alternative to total parenteral nutrition 2. To evaluate whether enteral feeding improve nutritional status after pancreaticoduodenectomy
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ampulla of Vater Cancer | Malignant Ampulla of Vater Neoplasm | CURATED_BROADER | 0.80 |
| Bile Duct Cancer | Malignant Bile Duct Neoplasm | CURATED_BROADER | 0.80 |
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Enteral Feeding and Total Parental Support | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- 1
- description
- 1\. Enteral Feeding
- interventionNames
- Procedure: Enteral Feeding and Total Parental Support
- type
- NO_INTERVENTION
- label
- 2
- description
- Total Parental support
- interventionNames
- Procedure: Enteral Feeding and Total Parental Support
Primary outcomes (1)
- measure
- To evaluate the impact of early postoperative enteral feeding
- timeFrame
- Postoperative 21 days
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Periampullar carcinoma * Pancreaticoduonectomy * KARNOFSKY PERFORMANCE SCALE \> 70 * No history of Major operation Exclusion Criteria: * Creatinine level\>3mg/L * Ascitis/portal hypertension * New York Heart Association class\>3 * COPD * Preoperative Radiotheraly/chemotherapy * Unresectable primary cancer * Palliative surgery
References
Publications (0)
Data not yet available